The $40,000 medicine may rid the blood of the virus but experts weren’t convinced it could prevent deaths
A medicine hailed as a ‘miracle’ drug that could eliminate hepatitis C may not actually cure the disease, a study claims.
Sick patients were offered hope with a new $40,000 direct-acting antiviral drug, which boasted it could clear the virus from the blood within 12 weeks.
The staggering price of the medicine was worth it to some because the contagious liver disease can lead to cancer and death. Continue reading